The development of microneedles (MNs) assisted drug delivery technologies have been
highly active for more than two decades. The minimally invasive and self-administered MN …

Extrusion bioprinting is an emerging technology to apply biomaterials precisely with living
cells (referred to as bioink) layer by layer to create three-dimensional (3D) functional …

Microneedles (MN) have the potential to become a highly progressive device for both drug
delivery and monitoring purposes as they penetrate the skin and pierce the stratum corneum …

Abstract The 'one-size-fits-all'approach followed by conventional drug delivery platforms
often restricts its application in pharmaceutical industry, due to the incapability of adapting to …

Microneedles (MNs) are minimally invasive devices, which have gained extensive interest
over the past decades in various fields including drug delivery, disease diagnosis …

Implantable drug delivery systems (IDDS) are an attractive alternative to conventional drug
administration routes. Oral and injectable drug administration are the most common routes …

The process of 3D printing (3DP) was patented in 1986; however, the research in the field of
3DP did not become popular until the last decade. There has been an increasing research …

Fungal infections affect millions of people globally and are often unreceptive to conventional
topical or oral preparations because of low drug bioavailability at the infection site, lack of …

Patient to patient variability is one of the issues when administering medications to
individuals with different health conditions, pharmacokinetic, age, fitness, gender, and race …

The traditional healthcare method follows 'one-size-fits-all'criteria, which shows some
limitations in rendering proper results due to varied pharmacokinetic traits of different …